1st Congress of Fatty Liver and Metabolic Syndrome
From Basic Science to Clinical Praxis BUDAPEST, Ramada Resort Hotel 12-14 November, 2009 Coorganizer COST B35 ActionOn the behalf of Organizing Committee and as the president of the Hungarian Association for the Study of Liver it is my great pleasure to invite you to participate in the 1st International Congress of Fatty Liver and Metabolic Diseases, which will be held in Budapest, Hungary, from November 12-14, 2009. The theme is: Fatty Liver and Metabolic Diseases, From Basic Science to Clinical Praxis. You will learn about the latest advances in all biomedical aspects and therapeutic modalities of hepatic steatosis, steatohepatitis, progression of fibrosis in the liver, concommitant hepatitis B or C virus infection, hepatocellular carcinoma and will discuss them with a select group of scientists in the field from all over the world.
Read more...
|
Ramada Resort Budapest is a four-star superior conference and wellness hotel offering unique services: it has 309 rooms, suites and apartments with internet connection; a conference centre with a capacity of almost 1000; a spa, wellness and fitness unit; an entertainment centre; indoor and outdoor car parks with a total capacity of more than 1000 and direct access to Aquaworld, one of the biggest indoor water theme parks in Europe.
Read more...
Confirmed keynote lectures of the conference include: - Giuseppe Poli (Turin, Italy): Lipid oxidation, inflammation and fibrosis
- Lajos Szollár (Budapest, Hungary): The metabolic syndrome
- Neven Zarkovic (Zagreb, Croatia): The relevance of lipid peroxidation in liver pathopysiology
- Thomas Baumert (Strasbourg, France): Hepatitis C virus infection and lipid metabolism
- László Halmy (Budapest, Hungary): Obesity and fatty liver
- Chrys Chatgilialoglu (Bologna, Italy): Trans fatty acids in membranes: from nutrition to radical stress
- Fiorella Biasi (Turin, Italy): Lipid oxidation and fibrogenesis in cancer progression
- Péter Fülöp (Debrecen, Hungary): Molecular biology of lipid accumulation in the liver
- Grzegorz Bartosz (Lodz, Poland): Reactive oxygen species: Destroyers or messengers in non-alcoholic fatty liver?
- Gabriella Lengyel (Budapest, Hungary): Fatty liver and respond to combined peginterferon and ribavirin treatment
- Jaroslav Vesely (Olomuc, Czech Republic) Peroxisome Proliferator-Activated Receptors in Liver Pathophysiology
- György Paragh (Debrecen, Hungary): The effect of statins on the hepatocyte function
- Tatjana Ábel (Budapest, Hungary): Statins in the therapy of fatty liver
- Peter Eckl (Salzburg, Austria): Toxicological properties of β-carotene in the liver
- Françoise Guéraud (Toulouse, France): Fate of 4-hydroxynonenal in vivo: disposition and
metabolic pathways - József Mandl (Budapest, Hungary): The role of endoplasmic reticulum in the metabolic syndrome
- János Fehér (Budapest, Hungary): Therapy modalities in non-alcoholic steatohepatitis
Registration Date
| Participant | Student/PhD Student Participant | Before April 30, 2009
| 660 EUR
| 400 EUR
| | After April 30, 2009 | 760 EUR
| 460 EUR
| | On-site | 800 EUR
| 500 EUR
| Daily registration fee
| 350 EUR
| 300 EUR
|
From Basic Science to Clinical Praxis- Molecular biology of lipid accumulation in the liver
- Pathology – pathophysiology
- Clinical form (fatty liver, NASH, HCC)
- Dyslipidaemia and fatty liver
- Fatty liver and viral (HBV, HCV) infection
|
|
|
|
Page 1 of 2 |